Tuesday, September 3, 2013


1 comment:

  1. Q: A 42-year-old patient is taking paroxetine for depression. As a part of a clinical trial, the patient is given serial doses of a noncompetitive serotonin receptor antagonist in addition to paroxetine. What will be the effect on the graded dose-response curve for paroxetine?

    A: Shifted downward because of a decrease in efficay (effect).